RCKT - FDA extends review period for Rocket gene therapy to June 30
2024-02-13 12:36:00 ET
More on Rocket Pharmaceuticals
- Rocket Pharmaceuticals: Gene Therapy Pioneer On A High
- Rocket Pharmaceuticals: Promising, But Not A Rocket At This Valuation
- Seeking Alpha’s Quant Rating on Rocket Pharmaceuticals
- Historical earnings data for Rocket Pharmaceuticals
- Financial information for Rocket Pharmaceuticals